Diagnosis and treatment of gastrointestinal stromal tumors of the stomach: Report of 28 cases

Annals of Clinical and Laboratory Science

Volumn 37, Issue 1, 2007, Pages 15-21

  Wu, Yafu ^a,b   Zhu, Xinhua ^a   Ding, Yitao ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

c KIT proto oncogene; CD117 marker; Gastric malignancies; Gastrointestinal stromal tumors

Indexed keywords

CD34 ANTIGEN; STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL STROMAL TUMOR; HEART INFARCTION; HEMIHEPATECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CHINA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; RETROSPECTIVE STUDIES; STOMACH;

EID: 33847229884     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001;136:383-389.
2. Fletcher C, Berman J, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Learly TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459-465.
3. Nishida T, Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 2000;15:1293-1301.
4. Miettinen M, Lasota J. Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1-12.
5. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005;29:52-68.
6. Dougherty MJ, Compton C, Talbert M, Wood WC. Sarcomas of the gastrointestinal tract: Separation into favorable and unfavorable prognostic groups by mitotic count. Ann Surg 1991;214:569-574.
7. Candelaria M, de la Garza J, Duenas-Gonzalez A. A clinical and biological overview of gastrointestinal stromal tumors. Med Oncol 2005;22:1-10.
8. Bauer S, Corless CL, Heinrich MC, Dirsch O, Antoch G, Kanja J, Seeber S, Schutte J. Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT. Cancer Chemother Pharmacol 2003:51:261-265.
9. Nickl N. Endoscopic approach to gastrointestinal stromal tumors. Gastrointest Endosc Clin N Am 2005;15:455-466.
10. Ando N, Goto H, Niwa Y, et al. The diagnosis of GI stromal tumors with Eus-guided fineneedle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002;55:37-43.
11. Trupiano J, Stewart R, Misick C, Appleman H, Goldblum J. Gastric stromal tumors, a clinicopathological study of 77 cases with correlation of features with non-aggressive and aggressive clinical behaviour. Am J Surg Path 2002;26:705-714.
12. Miettinen M, El-Rifal W, Sobin LH, Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 2002;33:478-483.
13. Di Matteo G, Pescarmona E, Peparini M, DiMatteo FM, Zeri KP, Mascagni D, Mele R, Maturo A, Redler A, DeAntoni E. Histopathological features and clinical course of the gastrointestinal stromal tumors. Hepatogastroenterol 2002;49:1013-1016.
14. Yamaguchi U, Hasegawa T, Masuda T, Sekine S, Kawai A, Chuman H, Shimoda T. Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows Arch 2004;445:142-150.
15. Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA, Fletcher CD. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol 2004;28:889-894.
16. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 2002;38(Suppl 5):S39-51.
17. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002;33:669-676.
18. Bilimoria M, Holtz DJ, Mirza NQ, Feig BW, Pisters PW, Patel S, Pollock RE, Benjamin RS, Papadopoulos NE, Plager C, Murphy A, Griffin JR, Burgess MA, Hunt KK. Tumor volume as a prognostic factor for sarcomatosis. Cancer 2002;94:2441-2446.
19. DeMatteo R, Lewis JJ, Leung D, Mudan S, Woodruff J, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-58.
20. Bucher P, Villiger P, Egger JF, Buhler LH, Morel P. Management of gastrointestinal stromal tumours: from diagnosis to treatment. Swiss Med Wkly 2004;134:145-153.
21. Burkill GJ, Badran M, Al-Muderis O, Thomas JM, Judson IR, Fisher C, Moskovic EC. Malignant gastrointestinal stromal tumor: Distribution, imaging features, and pattern of metastatic spread. Radiology 2003;226:527-532.
22. Van Oosterom AT, Judson I, Verweij J, Stroobants S, Di Paola ED, Dimitrijevic S, Martens M, Webb A, Sciot R, Van Glabbeke M, Silberman S, Nielsen OS. Safety and efficacy of imatinib (STI-571) in metastatic gastro-intestinal stromal tumors: A phase I study. Lancet 2001;358:1421-1423.
23. Shawer LK, Slamon D, Ullrich A. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 2002;1:117-123.
24. Joensuu H, Roberts PJ, Salomo-Rikala M, Andersson L, Tervahartiala P, Tuveson D, Silberman S, Capdeville R, Dimitrijevic S, Druker B, Demetri G. Effect of the tyrosine kinase inhibitor ST1571 in a patient with a metastatic gastrointestinal stromal tumor. NEJM 2001;344:1052-1056.
25. Bauer S, Hartmann JT, de Wit M, Lang H, Grabellus F, Antoch G, Niebel W, Erhard J, Ebeling P, Zeth M, Taeger G, Seeber S, Flasshove M, Schutte J. Resection of residual disease in patients with metastatic gastro-intestinal stromal tumors responding to treatment with imatinib. Int J Cancer 2005;117:316-325.